跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39 条关于
“Medicenna”
全部
39
临床试验
1
药物
3
机构
23
资讯
12
去年
Medicenna Secures Five New Patents for IL-2 and IL-4 Superkine Immunotherapies
28天前
Medicenna Therapeutics Advances Oncology Immunotherapy Pipeline Ahead of September Healthcare Conferences
11个月前
Medicenna to Present Updated MDNA11 Clinical Data at ESMO Immuno-Oncology Congress 2025
去年
Medicenna to Present MDNA11 ABILITY-1 Trial Update and Novel MDNA113 Data at AACR 2025
去年
Medicenna Reports 78% Disease Control Rate for MDNA11-KEYTRUDA Combination in Advanced Cancer Trial
2年前
Medicenna Presents Preclinical Data on IL-2 Super-Antagonist MDNA209 and Anti-PD1-IL-2 BiSKIT MDNA113
10个月前
Medicenna Partners with Italian Foundation to Launch NEO-CYT Trial Testing MDNA11 in High-Risk Melanoma
去年
Medicenna's MDNA11 Shows Promise in Advanced Solid Tumors: Updated Phase 1/2 Data
9个月前
Medicenna's MDNA11 Shows Promising Anti-Tumor Activity in Advanced Solid Tumors at ESMO-IO Congress 2025
去年
IL-2 Inhibitor Pipeline Expands with 20+ Companies Developing 22+ Therapeutic Candidates
第 1 页,共 2 页
上一页
下一页